Table of Content

1 Viral Vaccines Market Introduction and Overview
1.1 Viral Vaccines Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Viral Vaccines Industry Dynamic Analysis
1.5.1 Viral Vaccines Market Trends Analysis
1.5.2 Viral Vaccines Market Drivers Analysis
1.5.3 Viral Vaccines Market Challenges Analysis
1.5.4 Viral Vaccines Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Viral Vaccines Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Viral Vaccines Revenue and Share by Type
3 Global Viral Vaccines Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Viral Vaccines Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Viral Vaccines Market Size (2019-2024)
4.2 Viral Vaccines Growth Insights by Regions
4.2.1 Viral Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Viral Vaccines Revenue Market Size by Regions (2019-2024)
4.2.3 North America Viral Vaccines Market Size (2019-2024)
4.2.4 Europe Viral Vaccines Market Size (2019-2024)
4.2.5 Asia-Pacific Viral Vaccines Market Size (2019-2024)
4.2.6 Latin America Viral Vaccines Market Size (2019-2024)
4.2.7 Middle East & Africa Viral Vaccines Market Size (2019-2024)
5 North America
5.1 North America Viral Vaccines Revenue by Countries
5.1.1 North America Viral Vaccines Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Viral Vaccines Revenue by Countries
6.1.1 Asia Pacific Viral Vaccines Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Viral Vaccines Revenue by Countries
7.1.1 Europe Viral Vaccines Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Viral Vaccines Revenue by Countries
8.1.1 Latin America Viral Vaccines Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Viral Vaccines Revenue by Countries
9.1.1 Middle East & Africa Viral Vaccines Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Viral Vaccines Market Competition, by Players
10.1 Global Viral Vaccines Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Viral Vaccines Players Market Share in 2023
10.2.2 Top 6 Viral Vaccines Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Viral Vaccines Players Head Office, Business Provided
10.4 Viral Vaccines Mergers & Acquisitions
10.5 Viral Vaccines New Entrants and Expansion Plans
11 Players Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Profile
11.1.2 Viral Vaccines Product Overview
11.1.3 Merck & Co., Inc. Viral Vaccines Market Performance (2019-2024)
11.1.4 Merck & Co., Inc. Business Overview
11.1.5 Recent Developments and Plans
11.2 Novartis, Inc.
11.2.1 Novartis, Inc. Company Profile
11.2.2 Viral Vaccines Product Overview
11.2.3 Novartis, Inc. Viral Vaccines Market Performance (2019-2024)
11.2.4 Novartis, Inc. Business Overview
11.2.5 Recent Developments and Plans
11.3 Emergent BioSolutions Inc.
11.3.1 Emergent BioSolutions Inc. Company Profile
11.3.2 Viral Vaccines Product Overview
11.3.3 Emergent BioSolutions Inc. Viral Vaccines Market Performance (2019-2024)
11.3.4 Emergent BioSolutions Inc. Business Overview
11.3.5 Recent Developments and Plans
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Profile
11.4.2 Viral Vaccines Product Overview
11.4.3 GlaxoSmithKline plc Viral Vaccines Market Performance (2019-2024)
11.4.4 GlaxoSmithKline plc Business Overview
11.4.5 Recent Developments and Plans
11.5 Serum institute of India Private Limited
11.5.1 Serum institute of India Private Limited Company Profile
11.5.2 Viral Vaccines Product Overview
11.5.3 Serum institute of India Private Limited Viral Vaccines Market Performance (2019-2024)
11.5.4 Serum institute of India Private Limited Business Overview
11.5.5 Recent Developments and Plans
11.6 Seqirus (CSL Limited)
11.6.1 Seqirus (CSL Limited) Company Profile
11.6.2 Viral Vaccines Product Overview
11.6.3 Seqirus (CSL Limited) Viral Vaccines Market Performance (2019-2024)
11.6.4 Seqirus (CSL Limited) Business Overview
11.6.5 Recent Developments and Plans
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Profile
11.7.2 Viral Vaccines Product Overview
11.7.3 Pfizer, Inc. Viral Vaccines Market Performance (2019-2024)
11.7.4 Pfizer, Inc. Business Overview
11.7.5 Recent Developments and Plans
11.8 Sanofi
11.8.1 Sanofi Company Profile
11.8.2 Viral Vaccines Product Overview
11.8.3 Sanofi Viral Vaccines Market Performance (2019-2024)
11.8.4 Sanofi Business Overview
11.8.5 Recent Developments and Plans
11.9 AstraZeneca plc
11.9.1 AstraZeneca plc Company Profile
11.9.2 Viral Vaccines Product Overview
11.9.3 AstraZeneca plc Viral Vaccines Market Performance (2019-2024)
11.9.4 AstraZeneca plc Business Overview
11.9.5 Recent Developments and Plans
11.10 Novavax, Inc.
11.10.1 Novavax, Inc. Company Profile
11.10.2 Viral Vaccines Product Overview
11.10.3 Novavax, Inc. Viral Vaccines Market Performance (2019-2024)
11.10.4 Novavax, Inc. Business Overview
11.10.5 Recent Developments and Plans
12 Global Viral Vaccines Forecast Market Insights by Type
12.1 Global Viral Vaccines Revenue Market Forecast by Type (2024-2030)
13 Global Viral Vaccines Forecast Market Insights by Application
13.1 Viral Vaccines Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Viral Vaccines Forecast Market Size (2024-2030)
14.2 Viral Vaccines Growth Forecast Insights by Regions
14.2.1 Viral Vaccines Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Viral Vaccines Forecast Market Size (2024-2030)
14.2.3 Europe Viral Vaccines Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Viral Vaccines Forecast Market Size (2024-2030)
14.2.5 Latin America Viral Vaccines Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Viral Vaccines Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer